Acute Decompensated Heart Failure, Aging, Frailty, Rehabilitation, Fidelity, ExerciseIntroductionAcute decompensated heart failure (ADHF) is the leading causeof hospitalization in older adults. Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial is a multi-site clinical trial to...
The Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial was designed to address this important gap in the management of acute decompensated heart failure in older hospitalized patients, regardless of ejection fraction. The REHAB-HF trial was a multicenter, randomized, ...
References: 1. Wies JT, Humphreys H, Latham M, et al. A randomized placebo-controlled trial of PT for RTC tendinopathies [abstract]. J Orthop Sports Phys Ther. 2005;35:A5. 2. Reinold MM, Escamilla R, Wilk KE. Current Concepts in the Scientific and Clinical Rationale Behind Exercises ...
SSB Radio: Sailor 6301 MF/HFMonitoring System: Benetti OEM Navigation Equipment Radar: Furuno GPS: Furuno Navnet 3DAIS: Furuno FA-50Automatic Pilot: Navis - AP 3000Depth Sounder: FurunoCompass: Furuno Sat CompassNorthrop Gruman MagneticMonitors: (2) x SeatronxNavsystem: Timezero ENTERTAINMENT ...
The randomized, single-center, single-blinded trial assessed the effect of a 12-week tele-supervised home-based exercise training program on anthropometric, respiratory, functional, and CV parameters after a hospitalization with COVID-19. The final analysis comprised 32 adults, 12 in the exercise ...
学术范收录的Journal Effect of the patient education - Learning and Coping strategies - in cardiac rehabilitation on return to work at one year: a randomised controlled trial show (LC-REHAB).,目前已有全文资源,进入学术范阅读全文,查看参考文献与引证文献,
北京时间5月16日晚20点整,美国心脏病学会第70届年会(ACC.21)第二场Late-Breaking Clinical Trial s在Gregory D. Curfman教 授的主持下,先后公布了REHAB-HF、DARE-19、VOYAGER PAD、STRENGTH、PRADA以及ANGPTL3相关的六项重磅研究的最新结果。 速览模式(约2分钟) ACC.21 | LBCT Ⅱ REHAB-HF 个体化的心脏康复...
In fact, patients using specially designed health tools on their smartphones and through a Web-based portal lost four times as much weight compared with those undergoing 12 weeks of cardiac rehabilitation alone. This randomized controlledtrialis the first in the United States to look at how adding...
The REMATCH trial: Long-term use of a left ventricular assist device for end-stage heart failure Background: uptake ≤12 mL · kg · min (later increased to 14 mL · kg · min). Patient eligibility was approved by a gatekeeper at the coordinating cente... SA Hunt,EA Rose - 《...
Active movement-assistive devices aim to increase the quality of life for patients with neuromusculoskeletal disorders. This technology requires interaction between the user and the device through a control interface that detects the user’s movement int